Introduction: Viral hepatitis B is a public health problem worldwide. The objective of this study was to determine the epidemiological and diagnostic profile of chronic carriers of hepatitis B virus seen for gastroenterology consultations in Parakou, Republic of Benin. Patients and Methods: This was a cross-sectional and descriptive study with retrospective data collection. Patients seen for gastroenterology consultations from January 1, 2017 to June 30, 2021 at the Regional Teaching Hospital of Borgou/Alibori (CHUD-B/A) and having been diagnosed as chronic carriers of hepatitis B virus were included. A minimum initial assessment was required to be included. The minimum sample size was calculated with Schwartz formula. The variable of interest was the detection of HBsAg twice and at least 6 months apart. The other variables studied were sociodemographic, clinical and paraclinical data. The data collected were analyzed using SPSS 17 software. Results: A total of 2786 patients were seen for gastroenterology consultations, including 1126 (40.4%) HBsAg-positive patients. Among them, 417 patients met the inclusion criteria and were the subject of the present study. The average age of the patients was 34.8 ± 10.5 years. Two hundred and forty-seven patients (65.7%) were male, representing a sex ratio of 1.9. The discovery of positive HBsAg status was made during systematic screening in 231 patients (55.4%). Scarifications were noted in 373 patients (89.4%). Asthenia was reported in 184 patients (44.1%). Co-infections with human immunodeficiency virus, hepatitis C and D viruses were 0% (0 in 92), 2.8% (4 in 146) and 14.3% (2 in 146), respectively. During the initial assessment, 274 patients (65.7%) were sero-negative for chronic HBeAg infection, 21 (5%) had clinically significant fibrosis including 16 (3.8%) at the stage of cirrhosis and 7 patients (5.4%) had hepatocellular carcinoma. Conclusion: In Parakou, chronic hepatitis B virus infection is common and affects young people with a male predominance. Asthenia is a non-specific symptom and the most reported by the patients. Around 5 out of 100 patients are seen for consultations at the stage of complication. Emphasis must be placed on early detection and subsidy for pre-therapeutic assessment.
References
[1]
Organisation Mondiale de la Santé (OMS) (2020) Principaux repères sur l’hépatite B. https://www.who.int/fr/news-room/fact-sheets/detail/hepatitis-b
[2]
Organisation Mondiale de la Santé (OMS) (2016) Lignes directrices pour la prévention, les soins et le traitement en faveur d’une personnes atteintes d’une infection à hépatite B chronique. http://remed.org/ressources/lignes-directrices-pour-la-prevention-les-soins-et-le-traitement-en-faveur-des-personnes-atteintes-dune-infection-a-hepatite-b-chronique/
[3]
Organisation Mondiale de la Santé (OMS) (2016) Prévention, soins et traitement de l’hépatite virale dans la région africaine: cadre d’action 2016-2020. Rapport secrétariat point 14. https://www.afro.who.int/sites/default/files/sessions/working_documents/afr-rc66-12_fr1111_0.pdf
[4]
Stanaway, J.D., Flaxman, A.D., Naghavi, M., Fitzmaurice, C., Vos, T., Abubakar, I., et al. (2016) The Global Burden of Viral Hepatitis from 1990 to 2013: Findings from the Global Burden of Disease Study 2013. Lancet, 388, 1081-1088. https://doi.org/10.1016/S0140-6736(16)30579-7
[5]
Hommel, C., Deboscker, S., Foegle, J., Latrech-Jung, C., Vix, A., Badila, D., et al. (2014) Vaccination incomplète contre l’hépatite B: intérêt d’un rattrapage tardif? Feuillet de Biologie, 55, 77-82.
[6]
Kodjoh, N. (2015) Situation de la lutte contre les hépatites B et C en Afrique. Mé-decine et Santé Tropicales, 22, 141-144. https://doi.org/10.1684/mst.2015.0439
[7]
Konaté, A. (2012) Epidémiologie de l’infection par le virus de l’hépatite B en Afrique. Développement et Santé, 200, 11-17.
[8]
Kpossou, A.R., Paraiso, M.N., Sokpon, C.N., Alassan, K.S., Vignon, R.K., Keke, R.K., et al. (2020) Hépatite virale B lors d’une campagne de dépistage en population générale au Bénin: séroprévalence et facteurs associés. Pan African Medical Journal, 37, Article No. 247. https://doi.org/10.11604/pamj.2020.37.247.26070
[9]
Alassan, K.S., Imorou, R.S., Sonombiti, H. and Salifou, K. (2019) Séroprévalence et facteurs associés à l’hépatite virale B chez les gestantes à Parakou en République du Bénin. Pan African Medical Journal, 33, Article No. 226. https://doi.org/10.11604/pamj.2019.33.226.19429
[10]
Dovonou, A.C., Amidou, S.A., Kpangon, A.A., Traoré, Y.A., Godjedo, T.P.M. and Satondji, A.J. (2015) Prévalence de l’hépatite B chez les personnes infectées par le VIH à Parakou au Bénin. Pan African Medical Journal, 20, Article No. 125. https://doi.org/10.11604/pamj.2015.20.125.6061
[11]
Katilé, D., Konaté, I., Goita, D., Kaboré, M., Dicko, M.Y., Mallé, O., et al. (2018) Prévalence de l’antigène HBs et profil sérologique du virus de l’hépatite B en consultation de médecine générale à l’hôpital régional de Kayes au Mali. Health Sciences and Disease, 19, 21-29.
[12]
Organisation Mondiale de la Santé (OMS) (2020) Questions-réponses: nouvelles recommandations de l’OMS pour la prévention de la transmission mère-enfant du virus de l’hépatite B. https://www.who.int/fr/news-room/questions-and-answers/item/q-a-new-who-recommendations-for-prevention-of-mother-to-child-transmission-of-hepatitis-b-virus
[13]
Kpossou, A.R., Séhounou, J., Wanvoegbe, F.A. and Vignon, R.K. (2019) Hépatite virale B et C: aspects épidémiologiques et cliniques au Centre National Hospitalier et Universitaire de Cotonou. Médecine d’Afrique Noire, 6601, 5-12.
[14]
Mongo-Onkouo, A., Itoko Okombi, R., Boumba, A., Niama, F.R. and Ahoui-Apendi, C.P. (2018) Seroprevalence and Molecular Biodiversity of Hepatitis B and Delta virus Infections in the Republic of Congo. Open Journal of Gastroenterology, 8, 448-454. https://doi.org/10.4236/ojgas.2018.812046
[15]
Kodjoh, N., Latoundji, S.B., Kpossou, A.R., Alassan, K.S., Vignon, R. and Houinato, D. (2015) Connaissances et croyances des patients en matière d’hépatites chroniques B et C en République du Bénin. Journal Africain d’Hépatologie et Gastroentérologie, 9, 2-6. https://doi.org/10.1007/s12157-014-0571-y
[16]
Diallo, S., Bassène, M.L., Gueye, M.N., Thioubou, M.A., Dia, D., Mbengue, M., et al. (2018) Hépatite virale B: aspects cliniques, paracliniques et évolutifs dans le service d’Hépato Gastroentérologie de l’Hôpital Aristide Le Dantec: à propos de728 cas. Pan African Medical Journal, 31, Article No. 82. https://doi.org/10.11604/pamj.2018.31.82.14725
[17]
Montella, M., D’Arena, G., Crispo, A., Capunzo, M. and Nocerino, F. (2015) Role of Sex Hormones in the Development and Progression of Hepatitis B Virus: Associated Hepatocellular Carcinoma. International Journal of Endocrinology, 2015, Article ID: 854530. https://doi.org/10.1155/2015/854530
[18]
Angounda, B.M., Dzia Bokilo, A., Boumba, L.M.A., Itoua, C., Ahombo, G., Moukassa, D., et al. (2014) Prevalence of Serologic Markers and Risk Factors for Hepatitis B Virus among Pregnant Women in Brazzaville Congo. International Journal of Science and Research, 5, 1907-1912. https://doi.org/10.21275/v5i1.SUB158155
[19]
Kpossou, A., Wangoegbe, F., Abattan, C., Vignon, R., Sokpon, C., Sehounou, J. (2020) Hépatites virales B et C: Aspects paracliniques et évolutifs au Centre National Universitaire de Cotonou. Les annales de l’Université de Parakou, 10, 10-13.
[20]
Kpossou, A.R., Zomahoun, A.M.O., Sogbo, F., Vignon, R.K., Sokpon, C.N.M., Sehonou, J., et al. (2019) Influence de l’infection par le virus de l’hépatite D sur le profil évolutif de l’infection par le virus de l’hépatite B à Cotonou. Médecine d’Afrique Noire, 66, 493-498.
